Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
13 participants
INTERVENTIONAL
2011-02-11
2016-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cortical rTMS as a Tool to Change Brain Reactivity to Alcohol Cues
NCT02939313
Cerebellar Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Alcohol Use Disorder
NCT03829761
Evaluation of Bilateral HF-rTMS on Abstinence in Alcohol Use Disorder Patients With Executive Dysfunction
NCT04997330
Deep Repetitive Transcranial Magnetic Stimulation for Alcohol Use Disorder
NCT02691390
Theta Burst Stimulation as a Tool to Decrease Drinking in Treatment-seeking Alcohol Users
NCT04154111
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
150 detoxified patients are randomized either to a high frequency rTMS over the left DLPFC (n = 75) or a sham stimulations (n = 75). Alcohol craving is determined with the Obsessive Compulsive Drinking Scale. Patients are allocated to active and sham rTMS in a 1: 1 ratio, such that 75 patients received active and 75 patients sham rTMS to the left DLPFC (10 Hz frequency, total 10 sessions). The Alcohol Craving Questionnaire (ACQ-NOW) and the Obsessive Compulsive Drinking Scale (OCDS) are administered to measure the severity of alcohol craving at baseline, after the last rTMS session and day 15, M1, M3, M6 after. Alcohol drinking is evaluated with Timeline Followback (TLFB).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
active rTMS
High frequency (10HZ) on the left DLPFC
rTMS (repetitive transcranial magnetic stimulation)
Frequency (10hz) 120% motor threshold 10 sessions
sham rTMS
rTMS (repetitive transcranial magnetic stimulation)
Frequency (10hz) 120% motor threshold 10 sessions
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
rTMS (repetitive transcranial magnetic stimulation)
Frequency (10hz) 120% motor threshold 10 sessions
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Detoxified inpatients hospitalised for Alcohol Withdrawal for more than one week
* Giving written informed
Exclusion Criteria
* Age \< 18 years
* Withdrawal Assessment (CIWA-Ar) scores of \> 5
* Patients with major medical or neurological disorders or with a pacemaker or metal in any part of the body were excluded from the study.
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Institut National de la Santé Et de la Recherche Médicale, France
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Caroline DUBERTRET
Role: PRINCIPAL_INVESTIGATOR
Institut National de la Santé Et de la Recherche Médicale, France
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Louis Mourier Hospital
Colombes, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2010-A00727-32
Identifier Type: REGISTRY
Identifier Source: secondary_id
C10-21
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.